Anticoagulant agents useful in treatment of thrombosis

n anti-factor IX monoclonal antibody having self-limiting neutralizing activity against Factor IX and the identifying characteristics of SB 249413, SB 249415, SB 249417, SB 257731 or SB 257732 is claimed. Also claimed are an immunoglobulin heavy chain complementary determining region having an amino...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	FEUERSTEIN, GIORA ZEEV, PATEL, ARUNBHAI HARIBHAI, GROSS, MITCHELL STUART, PADLAN, EDUARDO AGUSTIN, SYLVESTER, DANIEL ROBERT, BLACKBURN, MICHAEL NEAL, CHURCH, WILLIAM ROBERT, NICHOLS, ANDREW JOHN
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA DERIVATIVES THEREOF ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS SUGARS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!